[Therapeutic use of triiodothyronine in myxedema]. 1963

V R KLIACHKO, and Z Z TSLAF

UI MeSH Term Description Entries
D009230 Myxedema A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips. Myxedemas
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3

Related Publications

V R KLIACHKO, and Z Z TSLAF
August 1956, Turk Tip Cemiyeti mecmuasi,
V R KLIACHKO, and Z Z TSLAF
September 1958, Revista clinica espanola,
V R KLIACHKO, and Z Z TSLAF
January 1970, Medicina,
V R KLIACHKO, and Z Z TSLAF
June 1986, Annals of internal medicine,
V R KLIACHKO, and Z Z TSLAF
November 1957, Ugeskrift for laeger,
V R KLIACHKO, and Z Z TSLAF
August 1957, A.M.A. archives of internal medicine,
V R KLIACHKO, and Z Z TSLAF
February 1955, Acta endocrinologica,
V R KLIACHKO, and Z Z TSLAF
May 1963, Medical times,
V R KLIACHKO, and Z Z TSLAF
May 1956, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
Copied contents to your clipboard!